AllianceBernstein’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-83,379
| Closed | -$11.4M | – | 3243 |
|
|
2020
Q3 | $11.4M | Sell |
83,379
-5,497
| -6% | -$584K | 0.01% | 987 |
|
|
2020
Q2 | $8.59M | Buy |
88,876
+25,976
| +41% | +$2.17M | 0.01% | 1061 |
|
|
2020
Q1 | $2.95M | Buy |
62,900
+800
| +1% | +$51.3K | ﹤0.01% | 1455 |
|
|
2019
Q4 | $4.53M | Sell |
62,100
-100,914
| -62% | -$6.12M | ﹤0.01% | 1489 |
|
|
2019
Q3 | $8.5M | Buy |
163,014
+12,956
| +9% | +$689K | 0.01% | 1116 |
|
|
2019
Q2 | $7.52M | Buy |
150,058
+80,698
| +116% | +$3.93M | ﹤0.01% | 1181 |
|
|
2019
Q1 | $3.61M | Buy |
69,360
+900
| +1% | +$41.5K | ﹤0.01% | 1563 |
|
|
2018
Q4 | $3.35M | Hold |
68,460
| – | – | ﹤0.01% | 1523 |
|
|
2018
Q3 | $4.46M | Buy |
68,460
+27,060
| +65% | +$1.59M | ﹤0.01% | 1359 |
|
|
2018
Q2 | $2.06M | Buy |
41,400
+21,300
| +106% | +$1.03M | ﹤0.01% | 1895 |
|
|
2018
Q1 | $981K | Hold |
20,100
| – | – | ﹤0.01% | 2266 |
|
|
2017
Q4 | $846K | Sell |
20,100
-1,100
| -5% | -$42.4K | ﹤0.01% | 2361 |
|
|
2017
Q3 | $908K | Buy |
21,200
+9,900
| +88% | +$316K | ﹤0.01% | 2323 |
|
|
2017
Q2 | $148K | Buy |
+11,300
| New | +$149K | ﹤0.01% | 3058 |
|
AllianceBernstein's MYOK Position: Q4 2020 in Review
AllianceBernstein sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 83,379 shares — an estimated $11.4M sold.
AllianceBernstein first reported a position in MYOK in Q2 2017 and held it in 14 quarters. The position peaked at $11.4M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- AllianceBernstein reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- AllianceBernstein sold 83,379 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $11.4M.
- AllianceBernstein first reported a position in MyoKardia, Inc. Common Stock in Q2 2017 and held it in 14 quarters.
- AllianceBernstein's MyoKardia, Inc. Common Stock position peaked at $11.4M in Q3 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on AllianceBernstein's 13F filing for Q4 2020, filed 8 Feb 2021.